Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland & Nanjing, China - November 16, 2022 Idorsia Ltd (SIX: IDIA, "Idorsia"), specialized in the discovery, development and
QUVIVIQ (daridorexant) – Europe's first dual orexin receptor antagonist – is now available for patients with chronic insomnia disorder in Italy and Germany streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Findings highlight the tough reality of living with chronic insomnia, particularly in the days that follow nights of disturbed sleepOver 80% of respondents surveyed reported their chronic insomnia